Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial.

Author: Almadana-PachecoVirginia, Fouz-RosónNatalia, Gómez-BasteroAna Paulina, Montemayor-RubioTeodoro, Montserrat-GarcíaSoledad, Polo-PadilloJuan, Romero-MuñozConcepción

Paper Details 
Original Abstract of the Article :
AIMS: Varenicline is used in smoking cessation. The aims of the trial were to test for differences between standard 1- and 0.5-mg doses (both twice daily during 8 weeks) in (1) abstinence, (2) adherence and (3) side effects. DESIGN: Open-label randomized parallel-group controlled trial with 1-year ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/add.13855

データ提供:米国国立医学図書館(NLM)

Varenicline: A Desert Oasis for Smoking Cessation

Smoking cessation, like a journey through a vast and arid desert, can be a challenging endeavor. This study, like a trusty guidebook, explores the efficacy of varenicline, a medication used to help smokers quit. The researchers, like seasoned explorers, embarked on a randomized controlled trial to compare the effectiveness of two different doses of varenicline.

Their journey, like a meticulous exploration of a complex landscape, involved comparing the effects of a standard 1 mg dose and a lower 0.5 mg dose of varenicline. The researchers carefully monitored abstinence rates, treatment adherence, and side effects, seeking to identify the most effective dose and approach. Their findings, like a map revealing a hidden oasis, offer valuable insights into the potential benefits of varenicline for smoking cessation.

Varenicline: A Potential Solution for Smoking Cessation

This study found no significant difference in smoking cessation effectiveness between the 1 mg and 0.5 mg doses of varenicline. Both doses resulted in comparable abstinence rates, adherence, and side effects. This finding, like the discovery of a refreshing spring in the desert, suggests that patients may have flexibility in choosing the dose that best suits their individual needs.

Navigating the Desert of Nicotine Dependence: Finding a Path to Freedom

This study highlights the importance of exploring diverse treatment options for smoking cessation. Varenicline, like a guidepost in the desert of nicotine dependence, offers a potential solution for those seeking to quit. By working closely with healthcare providers, patients can choose the most effective approach for their unique journey to freedom from smoking.

Dr.Camel's Conclusion

Smoking cessation can feel like a never-ending journey through a parched desert. This study offers a glimmer of hope, suggesting that varenicline can be a valuable tool for those seeking to break free from nicotine dependence. The choice of dose may be flexible, offering patients a path toward a healthier and smoke-free future. Remember, even in the harshest deserts, there is always the possibility of finding an oasis of freedom and well-being.

Date :
  1. Date Completed 2018-05-18
  2. Date Revised 2018-05-18
Further Info :

Pubmed ID

28449281

DOI: Digital Object Identifier

10.1111/add.13855

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.